NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 84 filers reported holding NEOS THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $93,000 | -41.5% | 35,664 | +40.5% | 0.00% | – |
Q2 2018 | $159,000 | -6.5% | 25,385 | +24.4% | 0.00% | – |
Q1 2018 | $170,000 | -19.4% | 20,406 | -1.7% | 0.00% | – |
Q4 2017 | $211,000 | +19.2% | 20,762 | +6.8% | 0.00% | – |
Q3 2017 | $177,000 | +3440.0% | 19,433 | +3009.3% | 0.00% | – |
Q2 2017 | $5,000 | -83.9% | 625 | -85.4% | 0.00% | – |
Q1 2017 | $31,000 | +933.3% | 4,270 | +714.9% | 0.00% | – |
Q4 2016 | $3,000 | 0.0% | 524 | 0.0% | 0.00% | – |
Q3 2016 | $3,000 | -40.0% | 524 | 0.0% | 0.00% | – |
Q2 2016 | $5,000 | -66.7% | 524 | -65.0% | 0.00% | – |
Q1 2016 | $15,000 | – | 1,498 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 666,729 | $14,008,000 | 9.60% |
DSC Advisors, L.P. | 907,358 | $17,157,000 | 8.33% |
DAFNA Capital Management LLC | 63,400 | $1,332,000 | 1.32% |
WALL STREET ASSOCIATES | 199,343 | $4,188,000 | 0.80% |
Perceptive Advisors | 742,132 | $15,592,000 | 0.62% |
EMERALD MUTUAL FUND ADVISERS TRUST | 331,142 | $6,957,000 | 0.46% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 458,332 | $9,630,000 | 0.37% |
EMERALD ADVISERS, LLC | 321,313 | $6,751,000 | 0.35% |
Tourbillon Capital Partners, L.P. | 611,686 | $12,852,000 | 0.34% |
DSC Advisors, L.P. | 31,240 | $656,000 | 0.32% |